Optimized Cas9 nickases for prime editing, Amunix’s masked T cell engagers and more
BioCentury’s roundup of translational news
Researchers from Singapore’s Institute for Basic Science reported in Nature Communications a Cas9 nickase (nCas9) engineered to induce single-stranded DNA breaks for prime editing, while reducing the frequency of off-target double-strand breaks compared with commonly used nCas9 variants.
When incorporated into a prime editing system, the engineered nCas9 variant increased the frequency of correct edits without increasing the frequency of indels. The authors hold a patent on the tech...
BCIQ Target Profiles
Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)